237 related articles for article (PubMed ID: 24970265)
21. Ref-1/APE1 as a Transcriptional Regulator and Novel Therapeutic Target in Pediatric T-cell Leukemia.
Ding J; Fishel ML; Reed AM; McAdams E; Czader MB; Cardoso AA; Kelley MR
Mol Cancer Ther; 2017 Jul; 16(7):1401-1411. PubMed ID: 28446640
[TBL] [Abstract][Full Text] [Related]
22. Apurinic/Apyrimidinic endonuclease 1 regulates inflammatory response in macrophages.
Jedinak A; Dudhgaonkar S; Kelley MR; Sliva D
Anticancer Res; 2011 Feb; 31(2):379-85. PubMed ID: 21378315
[TBL] [Abstract][Full Text] [Related]
23. Design and synthesis of novel quinone inhibitors targeted to the redox function of apurinic/apyrimidinic endonuclease 1/redox enhancing factor-1 (Ape1/ref-1).
Nyland RL; Luo M; Kelley MR; Borch RF
J Med Chem; 2010 Feb; 53(3):1200-10. PubMed ID: 20067291
[TBL] [Abstract][Full Text] [Related]
24. Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor beta.
Bai Y; Liang S; Yu W; Zhao M; Huang L; Zhao M; Li X
Mol Vis; 2014; 20():1258-70. PubMed ID: 25352735
[TBL] [Abstract][Full Text] [Related]
25. The redox function of apurinic/apyrimidinic endonuclease 1 as key modulator in photodynamic therapy.
Franchi LP; de Freitas Lima JEB; Piva HL; Tedesco AC
J Photochem Photobiol B; 2020 Oct; 211():111992. PubMed ID: 32805556
[TBL] [Abstract][Full Text] [Related]
26. The Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis.
Zou GM; Karikari C; Kabe Y; Handa H; Anders RA; Maitra A
J Cell Physiol; 2009 Apr; 219(1):209-18. PubMed ID: 19097035
[TBL] [Abstract][Full Text] [Related]
27. Ape1 regulates WNT/β-catenin signaling through its redox functional domain in pancreatic cancer cells.
Jiang S; Zhu L; Tang H; Zhang M; Chen Z; Fei J; Han B; Zou GM
Int J Oncol; 2015 Aug; 47(2):610-20. PubMed ID: 26081414
[TBL] [Abstract][Full Text] [Related]
28. Inhibitors of APE1 redox function effectively inhibit γ-herpesvirus replication in vitro and in vivo.
Hu J; Wang Y; Yuan Y
Antiviral Res; 2021 Jan; 185():104985. PubMed ID: 33271272
[TBL] [Abstract][Full Text] [Related]
29. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
30. Interactions of apurinic/apyrimidinic endonuclease with a redox inhibitor: evidence for an alternate conformation of the enzyme.
Su D; Delaplane S; Luo M; Rempel DL; Vu B; Kelley MR; Gross ML; Georgiadis MM
Biochemistry; 2011 Jan; 50(1):82-92. PubMed ID: 21117647
[TBL] [Abstract][Full Text] [Related]
31. Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization.
Murata T; He S; Hangai M; Ishibashi T; Xi XP; Kim S; Hsueh WA; Ryan SJ; Law RE; Hinton DR
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2309-17. PubMed ID: 10892878
[TBL] [Abstract][Full Text] [Related]
32. PKR promotes choroidal neovascularization via upregulating the PI3K/Akt signaling pathway in VEGF expression.
Zhu M; Liu X; Wang S; Miao J; Wu L; Yang X; Wang Y; Kang L; Li W; Cui C; Chen H; Sang A
Mol Vis; 2016; 22():1361-1374. PubMed ID: 27994435
[TBL] [Abstract][Full Text] [Related]
33. The redox function of APE1 is involved in the differentiation process of stem cells toward a neuronal cell fate.
Domenis R; Bergamin N; Gianfranceschi G; Vascotto C; Romanello M; Rigo S; Vagnarelli G; Faggiani M; Parodi P; Kelley MR; Beltrami CA; Cesselli D; Tell G; Beltrami AP
PLoS One; 2014; 9(2):e89232. PubMed ID: 24586617
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of YAP ameliorates choroidal neovascularization via inhibiting endothelial cell proliferation.
Yan Z; Shi H; Zhu R; Li L; Qin B; Kang L; Chen H; Guan H
Mol Vis; 2018; 24():83-93. PubMed ID: 29422766
[TBL] [Abstract][Full Text] [Related]
35. Soluble EphB4 regulates choroidal endothelial cell function and inhibits laser-induced choroidal neovascularization.
He S; Ding Y; Zhou J; Krasnoperov V; Zozulya S; Kumar SR; Ryan SJ; Gill PS; Hinton DR
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4772-9. PubMed ID: 16303978
[TBL] [Abstract][Full Text] [Related]
36. Repurposing bortezomib for choroidal neovascularization treatment via antagonizing VEGF-A and PDGF-D mediated signaling.
Liu Y; Feng M; Cai J; Li S; Dai X; Shan G; Wu S
Exp Eye Res; 2021 Mar; 204():108446. PubMed ID: 33476605
[TBL] [Abstract][Full Text] [Related]
37. APE1/Ref-1 prevents oxidative inactivation of ERK for G1-to-S progression following lead acetate exposure.
Wang YT; Tzeng DW; Wang CY; Hong JY; Yang JL
Toxicology; 2013 Mar; 305():120-9. PubMed ID: 23370007
[TBL] [Abstract][Full Text] [Related]
38. Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1).
Laev SS; Salakhutdinov NF; Lavrik OI
Bioorg Med Chem; 2017 May; 25(9):2531-2544. PubMed ID: 28161249
[TBL] [Abstract][Full Text] [Related]
39. Chemical Inhibition of Apurinic-Apyrimidinic Endonuclease 1 Redox and DNA Repair Functions Affects the Inflammatory Response via Different but Overlapping Mechanisms.
Oliveira TT; Fontes-Dantas FL; de Medeiros Oliveira RK; Pinheiro DML; Coutinho LG; da Silva VL; de Souza SJ; Agnez-Lima LF
Front Cell Dev Biol; 2021; 9():731588. PubMed ID: 34616737
[TBL] [Abstract][Full Text] [Related]
40. Mad2 haploinsufficiency protects hematopoietic progenitor cells subjected to cell-cycle stress in vivo and to inhibition of redox function of Ape1/Ref-1 in vitro.
Rohrabaugh SL; Hangoc G; Kelley MR; Broxmeyer HE
Exp Hematol; 2011 Apr; 39(4):415-23. PubMed ID: 21216274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
